PCOS Renamed Polyendocrine Metabolic Ovarian Syndrome

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, May 15, 2026 -- The condition known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS), reflecting its diverse and multisystem features, according to an article published online May 12 in The Lancet.

Helena J. Teede, M.B.B.S., Ph.D., from Monash University in Melbourne, Australia, and colleagues outlined the rigorous, multistep global consensus process for renaming PCOS to PMOS. Fifty-six leading academic, clinical, and patient organizations were engaged. Iterative global surveys, modified Delphi methods, nominal group technique workshops, and marketing and implementation analyses were used to identify principles that prioritized scientific accuracy, clarity, avoidance of stigma, cultural appropriateness, and feasibility of implementation.

The authors note there was priority for an accurate new name over retaining the PCOS acronym or a generic name. Evolution was prioritized over transformation in implementation approaches. Polyendocrine, metabolic, and ovarian terms were preferred, reflecting the multisystem pathophysiology. Cysts were omitted to improve accuracy, and endocrine, metabolic, and ovarian dysfunction were captured in the new name: polyendocrine metabolic ovarian syndrome, or PMOS.

"The agreed principles of the new name included patient benefit, scientific accuracy, ease of communication, avoidance of stigma, cultural appropriateness, and accompanying implementation," Teede said in a statement. "This change was driven with and for those affected by the condition and we are proud to have arrived at a new name that finally accurately reflects the complexity of the condition."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords